Breast Cancer Now media statements
We respond to reports U.K. government has drawn up proposals to increase cost-effectiveness thresholds used by NICE for medicines
Claire Rowney, chief executive at Breast Cancer Now, said:
We respond to latest waiting times data in England - August 2025
Responding to the latest cancer waiting times in England, published during Breast Cancer Awareness Month, Claire Rowney, chief executive at ...
We respond to new Lancet study suggesting new cancer cases worldwide could rise 61% by 2050
Claire Rowney, chief executive at Breast Cancer Now, said:
We respond to new study suggesting missing first screening appointment linked to higher risk of breast cancer death
Claire Rowney, chief executive at Breast Cancer Now, said:
We respond to the National Audit of Metastatic Breast Cancer (NAoMe) State of the Nation Report 2025
Claire Rowney, chief executive at Breast Cancer Now, said:
We respond to projections that 6.3 million cancer cases could be diagnosed in England between now and 2040
Claire Rowney, chief executive at Breast Cancer Now, said:
We respond to publication of Scottish Referral Guidelines for Suspected Cancer
Melanie Sturtevant, associate director of policy, evidence and influencing at Breast Cancer Now, said:
We respond to government plans for Diagnosis Connect
Helen Dickens, chief support officer at Breast Cancer Now, said:
We respond to the announcement from Heather Peace that her wife Ellie Dickinson has also been diagnosed with breast cancer
Sally Kum, associate director of nursing and health information at Breast Cancer Now said:
We respond to new analysis examining the impact of hormone therapy on risk of developing young-onset breast cancer
Dr Kotryna Temcinaite, head of research communications at Breast Cancer Now said:
We respond to the new Scottish Burden of Disease study
Melanie Sturtevant, associate director of policy and evidence, at Breast Cancer Now, said:
We respond to new cancer workforce reports from Royal College of Radiologists
Claire Rowney, chief executive at Breast Cancer Now, said: